These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 6688545

  • 1. Continuous infusion of 1,25-dihydroxyvitamin D3 stimulates bone turnover in the normal young mouse.
    Marie PJ, Travers R.
    Calcif Tissue Int; 1983 Jul; 35(4-5):418-25. PubMed ID: 6688545
    [Abstract] [Full Text] [Related]

  • 2. Contrasting effects of 1,25-dihydroxyvitamin D3 on bone matrix and mineral appositional rates in the mouse.
    Marie PJ, Hott M, Garba MT.
    Metabolism; 1985 Aug; 34(8):777-83. PubMed ID: 3839559
    [Abstract] [Full Text] [Related]

  • 3. Inhibition by aminohydroxypropylidene bisphosphonate (AHPrBP) of 1,25(OH)2 vitamin D3-induced stimulated bone turnover in the mouse.
    Marie PJ, Hott M, Garba MT.
    Calcif Tissue Int; 1985 May; 37(3):268-75. PubMed ID: 3926276
    [Abstract] [Full Text] [Related]

  • 4. Influence of magnesium supplementation on bone turnover in the normal young mouse.
    Marie PJ, Travers R, Delvin EE.
    Calcif Tissue Int; 1983 Sep; 35(6):755-61. PubMed ID: 6652550
    [Abstract] [Full Text] [Related]

  • 5. Vitamin D metabolites and bone mineralization in man.
    Bordier P, Rasmussen H, Marie P, Miravet L, Gueris J, Ryckwaert A.
    J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
    [Abstract] [Full Text] [Related]

  • 6. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
    Mortensen BM, Gautvik KM, Gordeladze JO.
    Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
    [Abstract] [Full Text] [Related]

  • 7. The effects of 1,25-dihydroxycholecalciferol, parathyroid hormone, and thyroxine on trabecular bone remodeling in adult dogs. A histomorphometric study.
    High WB, Capen CC, Black HE.
    Am J Pathol; 1981 Dec; 105(3):279-87. PubMed ID: 6895577
    [Abstract] [Full Text] [Related]

  • 8. Alkaline phosphatase inhibition by levamisole prevents 1,25-dihydroxyvitamin D3-stimulated bone mineralization in the mouse.
    Garba MT, Marie PJ.
    Calcif Tissue Int; 1986 May; 38(5):296-302. PubMed ID: 3087604
    [Abstract] [Full Text] [Related]

  • 9. Skeletal resistance to 1,25-dihydroxyvitamin D3 in osteopetrotic rats.
    Safadi FF, Hermey DC, Popoff SN, Seifert MF.
    Endocrine; 1999 Dec; 11(3):309-19. PubMed ID: 10786828
    [Abstract] [Full Text] [Related]

  • 10. Effects on cultured neonatal mouse calvaria of 1 alpha,25-dihydroxyvitamin D3, 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 26,26,26,27,27,27-hexafluoro-1 alpha,23S,25-trihydroxyvitamin D3.
    Harada M, Miyahara T, Miyata M, Tomita I, Okayachi H, Ikemoto Y, Higuchi S, Otomo S, Kozuka H, Ikekawa N.
    Bone Miner; 1992 Jul; 18(1):41-9. PubMed ID: 1422297
    [Abstract] [Full Text] [Related]

  • 11. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM, Gordeladze JO, Lyngdal PT, Aarseth HP, Gautvik KM.
    Miner Electrolyte Metab; 1993 Jul; 19(2):78-85. PubMed ID: 8377728
    [Abstract] [Full Text] [Related]

  • 12. Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse.
    Marie PJ, Travers R, Glorieux FH.
    Calcif Tissue Int; 1982 Mar; 34(2):158-64. PubMed ID: 6282410
    [Abstract] [Full Text] [Related]

  • 13. Effects of magnesium and lactose supplementation on bone metabolism in the X-linked hypophosphatemic mouse.
    Marie PJ, Travers R.
    Metabolism; 1983 Feb; 32(2):165-71. PubMed ID: 6827987
    [Abstract] [Full Text] [Related]

  • 14. Comparison of 22-oxacalcitriol and 1,25(OH)2D3 on bone metabolism in young X-linked hypophosphatemic male mice.
    Halstead LR, Weinstein RS, Cheng SL, Rifas L, Avioli LV.
    Am J Physiol; 1996 Jan; 270(1 Pt 1):E141-7. PubMed ID: 8772486
    [Abstract] [Full Text] [Related]

  • 15. Stimulation by 1,25-dihydroxyvitamin D3 of in vitro mineralization induced by osteoblast-like MC3T3-E1 cells.
    Matsumoto T, Igarashi C, Takeuchi Y, Harada S, Kikuchi T, Yamato H, Ogata E.
    Bone; 1991 Jan; 12(1):27-32. PubMed ID: 2054233
    [Abstract] [Full Text] [Related]

  • 16. Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture.
    Van Beek E, Van der Wee-Pals L, van de Ruit M, Nijweide P, Papapoulos S, Löwik C.
    J Bone Miner Res; 1993 Feb; 8(2):191-8. PubMed ID: 8442437
    [Abstract] [Full Text] [Related]

  • 17. [Comparative study of the effect of 1,25 dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on calcium homeostasis and bone tissue state in rats during hypokinesia].
    Sergeev IN, Blazheevich NV, Kaplanskiĭ AS, Shvets VN, Belakovskiĭ MS.
    Vopr Med Khim; 1987 Feb; 33(1):100-7. PubMed ID: 3495067
    [Abstract] [Full Text] [Related]

  • 18. Effect of 1,25-dihydroxyvitamin D3 treatment on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice.
    Ecarot B, Glorieux FH, Desbarats M, Travers R, Labelle L.
    J Bone Miner Res; 1995 Mar; 10(3):424-31. PubMed ID: 7785464
    [Abstract] [Full Text] [Related]

  • 19. Chronic administration of 1,25-dihydroxyvitamin D3: increased bone but impaired mineralization.
    Wronski TJ, Halloran BP, Bikle DD, Globus RK, Morey-Holton ER.
    Endocrinology; 1986 Dec; 119(6):2580-5. PubMed ID: 3780540
    [Abstract] [Full Text] [Related]

  • 20. 1,25 Dihydroxyvitamin D3 modifies cyclosporine-induced bone loss.
    Epstein S, Schlosberg M, Fallon M, Thomas S, Movsowitz C, Ismail F.
    Calcif Tissue Int; 1990 Sep; 47(3):152-7. PubMed ID: 2224590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.